ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory failure. Participants in the study will be treated with either a study drug plus current standard of care (SOC), or with placebo plus current SOC.
Epistemonikos ID: 010f9611ae0a6c30bad40aaafcf23ac83672085e
First added on: Apr 15, 2021